Printer Friendly Version  View printer-friendly version
<< Back
Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2005 On November 1, 2004

BOULDER, Colo.--(BUSINESS WIRE)--Oct. 27, 2004--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the first quarter of fiscal 2005 on Monday, November 1, 2004, at 4:30 p.m. eastern time and hold a conference call on Tuesday, November 2, 2004, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

    Conference Call Information

    Date: Tuesday, November 2, 2004

    Time: 9:00 a.m. eastern time

    Toll-Free: (800) 967-7140

    Toll: (719) 457- 2629

    Pass Code: 905572

    Web Cast:

There will be a replay of the conference call for one week, which can be accessed in the United States by dialing toll-free (888) 203-1112, and outside the United States (719) 457-0820. The access code is 905572. Replay of the call will also be available as a web cast on Array's web site at

Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to

CONTACT: Array BioPharma Inc.
Tricia Haugeto, 303-386-1193

SOURCE: Array BioPharma Inc.

ShareThis Copy and Paste